At a glance
- Originator Johnson & Johnson
- Class Antiasthmatics; Small molecules
- Mechanism of Action Mast cell tryptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 02 Dec 2003 Phase-I clinical trials in Asthma in USA (Inhalation)